Login using social networks
Sign up and discover a great amount of new opportunities!
If you already have an account, just sign in. We've missed you!
Sign up using social networks
Dr. Omkar Herlekar, chairman & managing director, Lasa Supergenerics, said: We are looking forward to receive such bulk orders from overseas customers in near future.
Moreover, we are working in making all our products fully backward integrated which shall boost return on capital of the company, we shall continue to remain committed to growth.
Lasa Supergenerics is a vertically integrated group spanning the entire veterinary, animal, and human healthcare value chain-from discovery to delivery, with established credentials in research, manufacturing, and global marketing.
The company's net profit surged to Rs 12.28 crore in Q4 FY22 from Rs 3.79 crore in Q4 FY21. Revenue from operations increased by 31% YoY to Rs 51.21 crore during the quarter.
Powered by Capital Market - Live News
The domestic equity benchmarks advanced on Wednesday, mirroring positi...
The domestic equity benchmarks ended near the day's high, with signifi...
The key equity indices traded with modest gains in mid-afternoon trade...
Union Minister of Commerce and Industry, Consumer Affairs, Food and Pu...